Asami Hishiki - Concepedia

Author

Asami Hishiki

Yokohama City University ORCID

Also Known As

A Hishiki, A. Hishiki, Asami HISHIKI, Asami Hishiki

Publications

841

Citations

H-Index

Concepts

All Affiliations

Yokohama City University University of Shizuoka Sanford Burnham Prebys Medical Discovery Institute The University of Tokyo St. Jude Children's Research Hospital

About

Asami Hishiki is an author at Yokohama City University specializing in natural sciences, molecular biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	181
2	Natural Sciences	4	4	181
3	Engineering	1	1	39
4	Applied Physics	1	1	39
5	Biomolecular Engineering	1	1	72

Asami Hishiki

Publications

787

Citations

H-Index

Page 1

	Year	Citations
Structural Basis for Novel Interactions between Human Translesion Synthesis Polymerases and Proliferating Cell Nuclear Antigen Asami Hishiki, Hiroshi Hashimoto, Tomo Hanafusa, Journal of Biological Chemistry	2009	154
Identification of Small Molecule Proliferating Cell Nuclear Antigen (PCNA) Inhibitor That Disrupts Interactions with PIP-box Proteins and Inhibits DNA Replication Chandanamali Punchihewa, Akira Inoue, Asami Hishiki, Journal of Biological Chemistry	2012	131
A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) Inhibits Repair of Interstrand DNA Cross-link, Enhances DNA Double Strand Break, and Sensitizes Cancer Cells to Cisplatin Akira Inoue, Sotaro Kikuchi, Asami Hishiki, Journal of Biological Chemistry	2014	95
Structure of a Novel DNA-binding Domain of Helicase-like Transcription Factor (HLTF) and Its Functional Implication in DNA Damage Tolerance Asami Hishiki, Kodai Hara, Yuzu Ikegaya, Journal of Biological Chemistry Dna Damage ToleranceCrystal StructureNovel Dna-binding DomainHiran DomainGenetics	2015	72
En bloc transfer of polyubiquitin chains to PCNA in vitro is mediated by two different human E2–E3 pairs Yuji Masuda, Miki Suzuki, Hidehiko Kawai, Nucleic Acids Research	2012	64
Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth Teruki Yanagi, Kiyoshi Tachikawa, Rachel P. Wilkie-Grantham, Molecular Therapy — Nucleic Acids	2016	52
Dynamic feature of mitotic arrest deficient 2–like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment–maintaining phosphoprotein (CAMP) Kodai Hara, Shota Taharazako, Masanori Ikeda, Journal of Biological Chemistry Mad2l2 StructureMolecular BiologyCytoskeletonCell CycleProtein 2	2017	49
Crystal structure of zinc‐finger domain of Nanos and its functional implications Hiroshi Hashimoto, Kodai Hara, Asami Hishiki, EMBO Reports Materials ScienceCrystal StructureFunctional NanomaterialsEngineeringNanomaterials	2010	39
Development of a DNA aptamer that binds to the complementarity-determining region of therapeutic monoclonal antibody and affinity improvement induced by pH-change for sensitive detection Taro Saito, Yutaka Shimizu, Kaori Tsukakoshi, Biosensors and Bioelectronics MedicineNatural SciencesImmunologyMolecular BiologyTherapeutic Monoclonal Antibody	2022	31
Regulation of HLTF-mediated PCNA polyubiquitination by RFC and PCNA monoubiquitination levels determines choice of damage tolerance pathway Yuji Masuda, Satoshi Mitsuyuki, Rie Kanao, Nucleic Acids Research Molecular RegulationGeneticsGenomic MechanismMolecular BiologyDamage Tolerance Pathway	2018	29

Page 1